Serum levels of inflammatory markers in type 2 diabetes patients with chronic periodontitis

Journal of Applied Oral Science

Volumn 22, Issue 2, 2014, Pages 103-108

  Longo, Priscila Larcher ^a   Artese, Hilana Paula Carillo ^a   Rabelo, Mariana de Sousa ^a   Kawamoto, Dione ^a   Foz, Adriana Moura ^a   Romito, Giuseppe Alexandre ^a   Dib, Sérgio Atala ^b   Mayer, Marcia Pinto Alves ^a  

^a UNIVERSITY OF SÃO PAULO   (Brazil)

^b FEDERAL UNIVERSITY OF SÃO PAULO   (Brazil)

Author keywords

Cytokines; Diabetes mellitus; Inflammation; Periodontitis

Indexed keywords

BIOLOGICAL MARKER; GLYCOSYLATED HEMOGLOBIN; INTERLEUKIN 6; INTERLEUKIN 8; MONOCYTE CHEMOTACTIC PROTEIN 1;

ADULT; AGED; ARTICLE; BLOOD; CHRONIC PERIODONTITIS; DIABETES MELLITUS; ENZYME LINKED IMMUNOSORBENT ASSAY; EVALUATION STUDY; FEMALE; HUMAN; MALE; MIDDLE AGED; NON INSULIN DEPENDENT DIABETES MELLITUS; NONPARAMETRIC TEST; PERIODONTICS; TOOTH PLAQUE;

ADULT; AGED; BIOLOGICAL MARKERS; CHEMOKINE CCL2; CHRONIC PERIODONTITIS; DENTAL PLAQUE INDEX; DIABETES COMPLICATIONS; DIABETES MELLITUS, TYPE 2; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; HEMOGLOBIN A, GLYCOSYLATED; HUMANS; INTERLEUKIN-6; INTERLEUKIN-8; MALE; MIDDLE AGED; PERIODONTAL INDEX; STATISTICS, NONPARAMETRIC;

EID: 84896482431     PISSN: 16787757     EISSN: 16787765     Source Type: Journal    
DOI: 10.1590/1678-775720130540     Document Type: Article

References (35)

1. American Diabetes Association. Standards of medical care in diabetes - 2011. Diabetes Care. 2011;34(Suppl 1):S11-61.
2. Amir J, Waite M, Tobler J, Catalfamo DL, Koutouzis T, Katz J, et al. The role of hyperglycemia in mechanisms of exacerbated inflammatory responses within the oral cavity. Cell Immunol. 2011;272(l):45-52.
3. Auyeung L, Wang PW, Lin RT, Hsieh CJ, Lee PY, Zhuang RY, et al. Evaluation of periodontal status and effectiveness of non-surgica treatment in patients with type 2 diabetes mellitus in Taiwan for a 1-year period. J Periodontol. 2012;83(5):621-8.
4. Azuma MM, Samuel RO, Gomes-Filho JE, Dezan-Junior E, Cintra LT, The role of IL-6 on apical periodontitis: a systematic review. Int Endod J. 2013. doi: 10.Ill 1/iej.12196. Epub ahead of print.
5. Behle JH, Sedaghatfar MH, Demmer RT, Wolf DL, Celenti R, Kebschull M, etal. Heterogeneity of systemic inflammatory responses to periodontal therapy. J Clin Periodontol. 2009;36(4):287-94.
6. Beisswenger PJ, Brown WV, Ceriello A, Le NA, Goldberg RB, Cooke JP, et al. Meal induced increases in C-reactive protein, interleukin-6 and tumour necrosis factor a are attenuated by prandial + basal insulin in patients with type 2 diabetes. Diabet Med. 2011;28(9):1088-95.
7. Correa FO, Gonçalves D, Figueredo CM, Bastos AS, Gustafsson A, Orrico SR. Effect of periodontal treatment on metabolic control, systemic inflammation and cytokines in patients with type 2 diabetes. J Clin Periodontol. 2010;37(l):53-8.
8. Costa FO, Miranda Cota LO, Pereira Lages EJ, Soares Dutra Oliveira AM, Dutra Oliveira PA, Cyrino RM, et al. Progression of periodontitis and tooth loss associated with glycemic control in individuals undergoing periodontal maintenance therapy: a 5-year follow-up study. J Periodontol. 2013;84(5):595-605.
9. Chen L, Luo G, Xuan D, Wei B, Liu F, Li J, et al. Effects of non-surgical periodontal treatment on clinical response, serum inflammatory parameters, and metabolic control in patients with type 2 diabetes: a randomized study. J Periodontal. 2012;83(4):435-43.
10. Duarte PM, Oliveira MC, Tambeli CH, Parada CA, Casati MZ, Nociti FH Jr. Overexpression of interleukin-lbeta and interleukin-6 may play an important role in periodontal breakdown in type 2 diabetic patients. J Periodontal Res. 2007;42(4):377-81.
11. Engebretson SP, Vossughi F, Hey-Hadavi J, Emingil G, Grbic JT The influence of diabetes on gingival crevicular fluid beta-glucuronidase and interleukin-8. J Clin Periodontol. 2006;33(11):784-90.
12. Figueredo CM, Gustafsson A. Increased amounts of laminin in GCF from untreated patients with periodontitis. J Clin Periodontol. 2000;27(5):313-8.
13. Görska R, Gregorek H, Kowalski J, Laskus-Perendyk A, Syczewska M, Madalihski K. Relationship between clinica parameters and cytokine profiles in inflamed gingival tissue and serum samples from patients with chronic periodontitis. J Clin Periodontol. 2003;30(12):1046-52.
14. Graves DT, Kayal RA. Diabetic complications and dysregulated innate immunity. Front Biosci. 2008;13(l):1227-39.
15. Haseeb M, Khawaja KI, Ataullah K, Munir MB, Fatima A. Periodontal disease in type 2 diabetes mellitus. J Coll Physicians Surg Pak. 2012;22(8):514-8.
16. Heitz-Mayfield LJ. Disease progression: identification of high-risk groups and individuals for periodontitis. J Clin Periodontol. 2005;32(Suppl 6):196-209.
17. Kardesler L, Buduneli N, Cetinkalp S, Kinane DF. Adipokines and inflammatory mediators after initial periodontal treatment in patients with type 2 diabetes and chronic periodontitis. J Periodontol. 2010;81(l):24-33.
18. Khosravi R, Ka K, Huang T, Khalili S, Nguyen BH, Nicolau B, et al. Tumor necrosis factor-a and interleukin-6: potential interorgan inflammatory mediators contributing to destructive periodonta disease in obesity or metabolic syndrome. Mediators Inflamm. 2013;2013:728987.
19. Koromantzos PA, Makrilakis K, Dereka X, Offenbacher S, Katsilambros N, Vrotsos IA, et al. Effect of non-surgical periodonta therapy on C-reactive protein, oxidative stress, and matrix metalloproteinase (MMP)-9 and MMP-2 levels in patients with type 2 diabetes: a randomized controlled study. J Periodontol. 2012;83(1):3-10.
20. Lalla E, Papapanou PN. Diabetes mellitus and periodontitis: a tale of two common interrelated diseases. Nat Rev Endocrinol. 2011;7(12):738-48.
21. Larsen CM, Faulenbach M, Vaag A, Ehses JA, Donath MY, Mandrup-Poulsen T. Sustained effects of interleukin-1 receptor antagonist treatment in type 2 diabetes. Diabetes Care. 2009;32(9):1663-8.
22. Litwak L, Goh SY, Hussein Z, Malek R, Prusty V, Khamseh ME. Prevalence of diabetes complications in people with type 2 diabetes mellitus and its association with baseline characteristics in the multinational Alchieve study. Diabetol Metab Syndr. 2013;5(1):57.
23. Mao XM, Liu H, Tao XJ, Yin GP, Li Q, Wang SK. Independent antiinflammatory effect of insulin in newly diagnosed type 2 diabetes. Diabetes Metab Res Rev. 2009;25(5):435-41.
24. Mealey B, Oates T; American Academy of Periodontology. Diabetes mellitus and periodontal diseases. J Periodontol. 2006;77(8):1289-303.
25. Nibali L, Fedele S, D'Aiuto F, Donos N. Interleukin-6 in ora diseases: a review. Oral Dis. 2012;18(3):236-43.
26. Odegaard JI, Ricardo-Gonzalez RR, Goforth MH, More CR, Subramanian V, Mukundan L, et al. Macrophage-specific PPARgamma controls alternative activation and improves insulin resistance. Nature. 2007;447(7148):1116-20.
27. Sakallioglu EE, Ayas B, Lütfioglu M, Keles GC, Acikgöz G, Firatli E. Gingival levels of monocyte chemoattractant protein-1 (MCP-1) in diabetes mellitus and periodontitis: an experimental study in rats. Clin Oral Investig. 2008;12(l):83-9.
28. Saremi, A, Nelson RG, Tulloch-Reid M, Hanson RL, Sievers ML, Taylor GW, et al. Periodontal disease and mortality in type 2 diabetes. Diabetes Care. 2005;28(l):27-32.
29. Shoelson SE, Lee J, Goldfine AB. Inflammation and insulin resistance. J Clin Invest. 2006;116(7):1793-801.
30. Southerland JH, Moss K, Taylor GW, Beck JD, Pankow J, Gangula PR, et al. Periodontitis and diabetes associations with measures of atherosclerosis and CHD. Atherosclerosis. 2012;222(1):196-201.
31. Southerland JH, Taylor GW, Moss K, Beck JD, Offenbacher S. Commonality in chronic inflammatory diseases: periodontitis, diabetes, and coronary artery disease. Periodontol 2000. 2006;40:130-43.
32. Sun WL, Chen LL, Zhang SZ, Wu YM, Ren YZ, Qin GM. Inflammatory cytokines, adiponectin, insulin resistance and metabolic control after periodontal intervention in patients with type 2 diabetes and chronic periodontitis. Intern Med. 2011;50(15):1569-74.
33. Talbert J, Elter J, Jared HL, Offenbacher S, Southerland J, Wilder RS. The effect of periodontal therapy on TNF-alpha, IL-6 and metabolic control in type 2 diabetics. J Dent Hyg. 2006;80(2):7-22.
34. Tanwir F, Tariq A. Effect of glycemic control on periodonta status. J Coll Physicians Surg Pak. 2012;22(6):371-4.
35. Venza I, Visalli Mi M, Cucinotta M, De Grazia G, Teti D, Venza M. Proinflammatory gene expression at chronic periodontitis and peri-implantitis sites in patients with or without type 2 diabetes. J Periodontol. 2010;81(1):99-108.